Position in OGN
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$113
-$417 QoQ
Shares Held
19
-74.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Riverview Trust Co holds $1,806,129 across 6 Drug Manufacturers - General names.
All Filings in OGN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $113 | 19 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $530 | 74 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $790 | 74 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $716 | 74 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $29,422 | 1,976 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $35,658 | 2,390 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $21,004 | 1,098 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $22,790 | 1,101 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $20,698 | 1,101 | Shares | Sole | 2024-04-12 | |
| 2023-09-30 | $53,677 | 3,092 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $48,112 | 2,312 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $54,378 | 2,312 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $64,685 | 2,316 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $60,886 | 2,602 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $87,850 | 2,603 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $99,410 | 2,846 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $73,841 | 2,425 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $81,811 | 2,495 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $78,615 | 2,598 | Shares | Sole | 2021-07-16 | |
| No filing history on record for this holder in this stock. | ||||||